Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK J TITI

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1649268525
CMS profile
210742
Location
LANCASTER, PA

General Payments · PY2018–2024

$5,358.26

  • Reported across 320 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$903.61

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $795.30 36
Education $108.31 2

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,062.32 79
PY2019 $1,939.79 128
PY2020 $592.63 36
PY2021 $56.52 3
PY2022 $247.79 10
PY2023 $555.60 26
PY2024 $903.61 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $27.82 01/10/2024 Food and Beverage Undisputed 01/23/2026 1104448355 CMS
AstraZeneca Pharmaceuticals LP $21.59 01/11/2024 Food and Beverage Undisputed 01/23/2026 1104322102 CMS
AstraZeneca Pharmaceuticals LP $15.62 02/28/2024 Food and Beverage Undisputed 01/23/2026 1105767434 CMS
AstraZeneca Pharmaceuticals LP $21.20 03/13/2024 Food and Beverage Undisputed 01/23/2026 1105693449 CMS
AstraZeneca Pharmaceuticals LP $16.46 03/20/2024 Food and Beverage Undisputed 01/23/2026 1104248077 CMS
AstraZeneca Pharmaceuticals LP $14.01 05/07/2024 Food and Beverage Undisputed 01/23/2026 1104560750 CMS
AstraZeneca Pharmaceuticals LP $15.05 05/09/2024 Food and Beverage Undisputed 01/23/2026 1104745351 CMS
AstraZeneca Pharmaceuticals LP $15.73 05/21/2024 Food and Beverage Undisputed 01/23/2026 1104317826 CMS
AstraZeneca Pharmaceuticals LP $21.20 06/17/2024 Food and Beverage Undisputed 01/23/2026 1105501722 CMS
AstraZeneca Pharmaceuticals LP $18.35 06/27/2024 Food and Beverage Undisputed 01/23/2026 1104465096 CMS
AstraZeneca Pharmaceuticals LP $16.51 07/02/2024 Food and Beverage Undisputed 01/23/2026 1104343196 CMS
AstraZeneca Pharmaceuticals LP $14.95 08/07/2024 Food and Beverage Undisputed 01/23/2026 1104245893 CMS
AstraZeneca Pharmaceuticals LP $17.27 09/17/2024 Food and Beverage Undisputed 01/23/2026 1104776626 CMS
AstraZeneca Pharmaceuticals LP $16.05 10/01/2024 Food and Beverage Undisputed 01/23/2026 1104415369 CMS
AstraZeneca Pharmaceuticals LP $17.60 10/07/2024 Food and Beverage Undisputed 01/23/2026 1105802509 CMS
AstraZeneca Pharmaceuticals LP $15.91 11/13/2024 Food and Beverage Undisputed 01/23/2026 1104414187 CMS
AstraZeneca Pharmaceuticals LP $23.32 11/25/2024 Education Undisputed 01/23/2026 1104268327 CMS
AstraZeneca Pharmaceuticals LP $14.97 12/17/2024 Food and Beverage Undisputed 01/23/2026 1105299520 CMS
BioCryst US Sales Co., LLC $30.22 07/17/2024 Food and Beverage Undisputed 01/23/2026 1117477724 CMS
CSL Behring $41.63 03/28/2024 Food and Beverage Undisputed 01/23/2026 1134644781 CMS
CSL Behring $30.99 11/05/2024 Food and Beverage Undisputed 01/23/2026 1134644917 CMS
GENZYME CORPORATION $39.23 01/22/2024 Food and Beverage Undisputed 01/23/2026 1139628510 CMS
GlaxoSmithKline, LLC. $25.28 05/08/2024 Food and Beverage Undisputed 01/23/2026 1116073745 CMS
GlaxoSmithKline, LLC. $25.28 07/09/2024 Food and Beverage Undisputed 01/23/2026 1116631318 CMS
GlaxoSmithKline, LLC. $18.28 12/04/2024 Food and Beverage Undisputed 01/23/2026 1116384056 CMS
Grifols USA, LLC $19.20 03/18/2024 Food and Beverage Undisputed 01/23/2026 1124712412 CMS
Grifols USA, LLC $21.38 05/21/2024 Food and Beverage Undisputed 01/23/2026 1124712416 CMS
Grifols USA, LLC $14.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 1124712414 CMS
Grifols USA, LLC $24.92 12/05/2024 Food and Beverage Undisputed 01/23/2026 1124712418 CMS
Mylan Specialty L.P. $24.25 01/29/2024 Food and Beverage Undisputed 01/23/2026 1147319548 CMS
Novartis Pharmaceuticals Corporation $33.75 01/24/2024 Food and Beverage Undisputed 01/23/2026 1087428722 CMS
Novartis Pharmaceuticals Corporation $26.89 03/27/2024 Food and Beverage Undisputed 01/23/2026 1087428724 CMS
Optinose US, Inc. $18.27 04/02/2024 Food and Beverage Undisputed 01/23/2026 1142170200 CMS
Optinose US, Inc. $21.81 10/30/2024 Food and Beverage Undisputed 01/23/2026 1142170290 CMS
Pharming Healthcare, Inc. $29.87 08/07/2024 Food and Beverage Undisputed 01/23/2026 1132169071 CMS
Pharming Healthcare, Inc. $23.69 08/15/2024 Food and Beverage Undisputed 01/23/2026 1132169079 CMS
SANOFI-AVENTIS U.S. LLC $84.99 08/22/2024 Education Undisputed 01/23/2026 1139628566 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.07 10/24/2024 Food and Beverage Undisputed 01/23/2026 1137688122 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.